Anuncia Medical, Inc.

Anuncia Medical, Inc. is a neurotherapeutic medical device company focused on cerebrospinal fluid (CSF) management and neurocritical care. The company addresses significant needs in hydrocephalus treatment and revision brain surgeries by developing clinically validated, noninvasive devices. Their flagship product, the ReFlow™ Mini Flusher, is an FDA-cleared device designed to prevent emergency revision surgeries caused by non-flowing shunts in hydrocephalus patients. This device is about 50% smaller than its predecessor and can be used with any shunt system brand, allowing for effective monitoring and treatment both at home and in clinical settings. Anuncia Medical aims to improve the quality of life for patients with hydrocephalus and similar CSF disorders by reducing the frequency of invasive surgeries. Their technology is suitable for a wide range of patients, from infants to older adults. The company has received recognition for its innovative approach, including an honorable mention in Fast Company’s 2021 World Changing Ideas Award and finalist status in the Arizona Governor’s innovation startup competition. Anuncia Medical is dedicated to empowering patients and clinicians with advanced technologies that enhance care and outcomes in neurocritical settings.

• Employees 15
• Founded 2014
• Total Funding $16126104